Brief: Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facility from Sixth Street

Apellis Pharmaceuticals

14/05/2024 13:45

May 14 (Reuters) - Apellis Pharmaceuticals Inc  APLS.O :
    * APELLIS PHARMACEUTICALS REFINANCES EXISTING DEBT WITH UP
TO $475
MILLION NON-DILUTIVE CREDIT FACILITY FROM SIXTH STREET
    * APELLIS ELIMINATES $366 MILLION PAYMENT OBLIGATIONS
    * APELLIS: NEW SENIOR SECURED CREDIT FACILITY MATURES ON MAY
13,
2030

Source text for Eikon:  ID:nGNX69GRWz 
Further company coverage:  APLS.O 

 ((Reuters.Briefs@thomsonreuters.com;))